The HPV vaccine is typically used to prevent infection from high-risk HPV strains that cause over 90% of cervical cancers.

J&J’s amivantamab (Rybrevant Faspro) shows a 42% response rate in advanced head & neck cancer, boosting FDA approval odds—see ...

Read more about ASCO results showing improved survival with TMC-I in recurrent or metastatic head and neck cancer.

Corbus Pharmaceuticals (NASDAQ:CRBP) executives and oncology specialists used an ASCO-linked discussion to outline the ...

Regimen showed benefit in advanced head and neck cancer ...

An injection that eradicated entire tumours in patients with otherwise treatment-resistant cancers in a trial has been ...

This guide for newly diagnosed patients provides key information to help you understand your options and have informed conversations with your oncologist. A diagnosis of head and neck cancer can bring ...

Head and neck cancer is the sixth most common cancer worldwide, and it affects around 12,800 people in the UK each year.

Please provide your email address to receive an email when new articles are posted on . Patients with head and neck cancer have a higher risk for depression than those with other cancers. Rates of ...

MSK surgeons are here to help anyone who needs advanced reconstructive surgery after head and neck cancer. We can help you whether you were treated for head and neck cancer at MSK or another hospital.